Medable Partners with Seqster to Integrate RWD into Decentralized Trials
Medable Inc. has announced a new partnership with Seqster to integrate real-time, real-world data streams into decentralized clinical trials in efforts to improve trial recruitment and participation.
“Patients want clinical trials to fit into their real-world experience, not the other way around,” said Dr. Michelle Longmire, CEO and co-founder of Medable. “Working with Seqster, we can integrate data sources and data streams to provide clinicians with a more holistic view of patient health.”
Medable and Seqster are also partnering with Datavant to integrate and link de-identified data across the entire patient journey, including electronic health records, claims, and diagnostics, as well as emerging sources such as genomics, wearable devices, socioeconomic and behavioral data and more.
For more information, click here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
